CurvaFix, Inc.
United States
- Bellevue, Washington
- 17/07/2023
- Series C
- $39,000,000
CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.
- Industry Medical Equipment Manufacturing
- Website https://curvafix.com/
- LinkedIn https://www.linkedin.com/company/curvafix-llc/
Related People
Steve DimmerFounder
United States -
Bellevue, Washington
30 years building medical technology companies. Deep experience leading development and commercialization of novel, disruptive health care solutions spanning diagnostic & therapeutic medical devices and drug delivery. Built world class teams in areas of orthopedics, pulmonology, oncology, diagnostics, and general surgery. Raised over $80 million from angels, VCs, family offices, and strategics. Inventor on over 100 U.S patents.
Andercore | $40,000,000 | (Feb 11, 2026)
Garner Health | $118,000,000 | (Feb 11, 2026)
NATILUS | $28,000,000 | (Feb 11, 2026)
tem | $75,000,000 | (Feb 11, 2026)
Entire | $60,000,000 | (Feb 11, 2026)
Lema AI | $24,000,000 | (Feb 11, 2026)
ZeroDrift | $2,000,000 | (Feb 11, 2026)
Force Equals | $2,200,000 | (Feb 11, 2026)
Bretton AI | $75,000,000 | (Feb 11, 2026)
Pelgo | $5,500,000 | (Feb 11, 2026)
Newo.ai | $25,000,000 | (Feb 11, 2026)
Equal Parts | $23,000,000 | (Feb 11, 2026)